<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02709486</url>
  </required_header>
  <id_info>
    <org_study_id>A4091057</org_study_id>
    <secondary_id>2013-004508-21</secondary_id>
    <secondary_id>OA 6-MONTH EU STUDY</secondary_id>
    <nct_id>NCT02709486</nct_id>
  </id_info>
  <brief_title>Study of the Analgesic Efficacy and Safety of Subcutaneous Tanezumab in Subjects With Osteoarthritis of the Hip or Knee.</brief_title>
  <official_title>A Phase 3 Randomized, Double-blind, Placebo-controlled, Multicenter Study Of The Analgesic Efficacy And Safety Of The Subcutaneous Administration Of Tanezumab In Subjects With Osteoarthritis Of The Hip Or Knee</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pfizer</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Eli Lilly and Company</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Pfizer</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Tanezumab is a monoclonal antibody that binds to and inhibits the actions of nerve growth
      factor (NGF). The Nerve Growth Factor Inhibitor (NGFI) class may offer an important
      breakthrough in the treatment of chronic pain and is under clinical investigation for the
      treatment of pain associated with osteoarthritis or other chronic pain conditions.

      The primary objective of this study is to demonstrate superior efficacy of tanezumab 5 mg and
      2.5 mg administered subcutaneously (SC) every 8 weeks versus placebo at Week 24 in subjects
      with osteoarthritis of the knee or hip. The 2.5 mg dose was shown to provide efficacy
      benefits with a favorable safety profile when administered intravenously in previous Phase 3
      clinical trials. The 5 mg dose is expected to provide added efficacy benefit over the 2.5 mg
      dose based on data from previous studies.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a randomized, double blind, placebo controlled, parallel group multicenter Phase 3
      study of the efficacy and safety of tanezumab when administered by SC injection for 24 weeks
      compared to placebo in subjects with osteoarthritis of the knee or hip. A total of
      approximately 810 subjects will be randomized to 1 of 3 treatment groups in a 1:1:1 ratio
      (ie, 270/group). The randomization will be stratified by index joint (hip or knee), and most
      severe Kellgren-Lawrence grade (of any knee or hip joint) at study entry (grade 2, 3 or 4).
      Subjects will receive up to three SC doses of one of the following treatments at an 8-week
      interval between each injection:

        1. tanezumab 2.5 mg;

        2. tanezumab 5 mg;

        3. Placebo to match tanezumab. The study is designed with a total (post-randomization)
           duration of 48 weeks and will consist of three periods: Screening (up to 37 days),
           Double-blind Treatment (24 weeks) and Safety Follow-up (24 weeks). The Screening Period
           (beginning up to 37 days prior to Randomization) includes a Washout Period (lasting a
           minimum of 2 days for all prohibited pain medications), if required, and an Initial Pain
           Assessment Period (the 7 days prior to Randomization/Baseline).

      Week 24 is the landmark analysis in this study. Subjects who do not complete the Double-blind
      Treatment period will enter and complete the 24-week Early-termination follow-up period.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">March 2, 2016</start_date>
  <completion_date type="Anticipated">November 29, 2018</completion_date>
  <primary_completion_date type="Anticipated">June 8, 2018</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>WOMAC Pain subscale.</measure>
    <time_frame>24 weeks.</time_frame>
    <description>Change from Baseline to Week 24 in the WOMAC Pain subscale.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>WOMAC Physical Function subscale</measure>
    <time_frame>24 weeks</time_frame>
    <description>Change from Baseline to Week 24 in the WOMAC Physical Function subscale.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Patient's Global Assessment of Osteoarthritis</measure>
    <time_frame>24 weeks</time_frame>
    <description>Change from Baseline to Week 24 in the Patient's Global Assessment of Osteoarthritis.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>WOMAC Pain subscale</measure>
    <time_frame>Weeks 2, 4, 8, 12, 16, and 32.</time_frame>
    <description>WOMAC Pain subscale change from Baseline to Weeks 2, 4, 8, 12, 16, and 32.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>WOMAC Physical Function subscale</measure>
    <time_frame>Weeks 2, 4, 8, 12, 16, and 32</time_frame>
    <description>WOMAC Physical Function subscale change from Baseline to Weeks 2, 4, 8, 12, 16, and 32.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient's Global Assessment of Osteoarthritis</measure>
    <time_frame>Weeks 2, 4, 8, 12, 16, and 32.</time_frame>
    <description>Patient's Global Assessment of Osteoarthritis (5 point Likert scale) change from Baseline to Weeks 2, 4, 8, 12, 16, and 32.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>OMERACT OARSI responder index</measure>
    <time_frame>Weeks 2, 4, 8, 12, 16, 24, and 32</time_frame>
    <description>OMERACT OARSI responder index at Weeks 2, 4, 8, 12, 16, 24, and 32.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cumulative distribution of percent change from Baseline in the WOMAC Pain subscale</measure>
    <time_frame>Week 16 and 24</time_frame>
    <description>Cumulative distribution of percent change from Baseline in the WOMAC Pain subscale score to Week 16 and 24 (endpoint for summary only).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Treatment Response: Reduction in the WOMAC Pain subscale of 30%, 50%, 70% and 90%</measure>
    <time_frame>Weeks 2, 4, 8, 12, 16, 24, and 32.</time_frame>
    <description>Treatment Response: Reduction in the WOMAC Pain subscale of 30%, 50%, 70% and 90%, at Weeks 2, 4, 8, 12, 16, 24, and 32.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Treatment Response: Reduction in the WOMAC Physical Function subscale of 30%, 50%, 70% and 90%</measure>
    <time_frame>Weeks 2, 4, 8, 12, 16, 24, and 32</time_frame>
    <description>Treatment Response: Reduction in the WOMAC Physical Function subscale of 30%, 50%, 70% and 90% at Weeks 2, 4, 8, 12, 16, 24, and 32.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cumulative distribution of percent change from Baseline in the WOMAC Physical Function subscale</measure>
    <time_frame>Week 16 and 24</time_frame>
    <description>Cumulative distribution of percent change from Baseline in the WOMAC Physical Function subscale score to Week 16 and 24 (endpoint for summary only).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Treatment Response: Improvement of ≥2 points in Patient's Global Assessment of Osteoarthritis</measure>
    <time_frame>Weeks 2, 4, 8, 12, 16, 24, and 32</time_frame>
    <description>Treatment Response: Improvement of ≥2 points in Patient's Global Assessment of Osteoarthritis at Weeks 2, 4, 8, 12, 16, 24, and 32.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Average pain score in the index knee or hip change</measure>
    <time_frame>Weeks 1, 2, 3, 4, 6, 8, 10, 12, 16, 20, 24, 28 and 32.</time_frame>
    <description>Average pain score in the index knee or hip change from Baseline to Weeks 1, 2, 3, 4, 6, 8, 10, 12, 16, 20, 24, 28 and 32.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>WOMAC Stiffness subscale change from Baseline</measure>
    <time_frame>Weeks 2, 4, 8, 12, 16, 24 and 32</time_frame>
    <description>WOMAC Stiffness subscale change from Baseline to Weeks 2, 4, 8, 12, 16, 24 and 32.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>WOMAC Average change from Baseline</measure>
    <time_frame>Weeks 2, 4, 8, 12, 16, 24, and 32.</time_frame>
    <description>WOMAC Average score change from Baseline to Weeks 2, 4, 8, 12, 16, 24, and 32.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>WOMAC Pain Subscale Item: Pain When Walking on a Flat Surface, change from Baseline</measure>
    <time_frame>Weeks 2, 4, 8, 12, 16, 24, and 32</time_frame>
    <description>WOMAC Pain Subscale Item: Pain When Walking on a Flat Surface, change from Baseline to Weeks 2, 4, 8, 12, 16, 24, and 32.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>WOMAC Pain Subscale Item: Pain When Going Up or Down Stairs, change from Baseline</measure>
    <time_frame>Weeks 2, 4, 8, 12, 16, 24, and 32.</time_frame>
    <description>WOMAC Pain Subscale Item: Pain When Going Up or Down Stairs, change from Baseline to Weeks 2, 4, 8, 12, 16, 24, and 32.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Work Productivity and Activity Impairment Questionnaire for Osteoarthritis (WPAI:OA) impairment scores change from Baseline</measure>
    <time_frame>Weeks 8, 16 and 24.</time_frame>
    <description>Work Productivity and Activity Impairment Questionnaire for Osteoarthritis (WPAI:OA) impairment scores change from Baseline to Weeks 8, 16 and 24.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>EQ 5D-5L Health State Utility and Five Items</measure>
    <time_frame>Weeks 8, 16 and 24.</time_frame>
    <description>EQ 5D-5L Health State Utility and Five Items (Mobility; Self-Care; Usual Activities; Pain/Discomfort; Anxiety/Depression) change from Baseline to Weeks 8, 16 and 24.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Reported Treatment Impact Assessment-Modified (mPRTI)</measure>
    <time_frame>Weeks 16 and 24.</time_frame>
    <description>Patient Reported Treatment Impact Assessment-Modified (mPRTI) at Weeks 16 and 24.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health Care Resource Utilization</measure>
    <time_frame>Weeks 32 and 48.</time_frame>
    <description>Health Care Resource Utilization at Baseline, and Weeks 32 and 48.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of discontinuation due to Lack of Efficacy</measure>
    <time_frame>24 weeks</time_frame>
    <description>Incidence of discontinuation due to Lack of Efficacy.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of rescue medication use</measure>
    <time_frame>Weeks 2, 4, 8, 12, 16, 24, and 32.</time_frame>
    <description>Usage of rescue medication (incidence and number of days of use) during Weeks 2, 4, 8, 12, 16, 24, and 32.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Amount of rescue medication taken</measure>
    <time_frame>Weeks 2, 4, 8, 12, 16 and 24.</time_frame>
    <description>Usage of rescue medication (amount taken) during Weeks 2, 4, 8, 12, 16 and 24.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of Subjects with Adverse Events.</measure>
    <time_frame>48 weeks</time_frame>
    <description>Adverse Events.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hematology testing</measure>
    <time_frame>Weeks 16 and 32.</time_frame>
    <description>Hematology testing</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood pressure</measure>
    <time_frame>Weeks 2, 4, 8, 12, 16, 24, 32 and 48.</time_frame>
    <description>Blood pressure in mmHg</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Electrocardiogram</measure>
    <time_frame>Weeks 24 and 48.</time_frame>
    <description>Electrocardiogram</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of individual adjudication outcomes</measure>
    <time_frame>48 weeks</time_frame>
    <description>The Adjudication Committee will be asked to review all possible or probable joint related safety events, total joint replacement, as well as investigator reported adverse events of osteonecrosis, rapidly progressive osteoarthritis, subchondral insufficiency fracture (spontaneous osteonecrosis of the knee [SPONK]) or pathologic fracture.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of all cause total joint replacements</measure>
    <time_frame>48 weeks</time_frame>
    <description>All cause total joint replacement as defined in the protocol.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Orthostatic (supine / standing) blood pressure assessments.</measure>
    <time_frame>Weeks 2, 4, 8, 12, 16, 24, 32 and 48.</time_frame>
    <description>Orthostatic (supine / standing) blood pressure assessments.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Survey of Autonomic Symptom scores.</measure>
    <time_frame>Week 24.</time_frame>
    <description>Survey of Autonomic Symptom scores.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neurologic exam (Neuropathy Impairment Score [NIS]).</measure>
    <time_frame>Weeks 2, 4, 8, 12, 16, 24, 32,and 48.</time_frame>
    <description>Neurologic exam (Neuropathy Impairment Score [NIS]).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anti-tanezumab antibody assessments.</measure>
    <time_frame>Weeks 8, 16, 24, 32 and 48.</time_frame>
    <description>Anti-tanezumab antibody assessments.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Musculoskeletal examination.</measure>
    <time_frame>Weeks 2, 4, 8, 12, 16, 24, 32 and 48.</time_frame>
    <description>Physical examination of all major joints.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to discontinuation due to Lack of Efficacy.</measure>
    <time_frame>24 weeks</time_frame>
    <description>Time to discontinuation due to Lack of Efficacy.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical chemistry testing</measure>
    <time_frame>Weeks 16 and 32.</time_frame>
    <description>Clinical chemistry testing</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>General examination</measure>
    <time_frame>Week 24</time_frame>
    <description>General examination including cardiovascular, respiratory, abdominal and skin systems.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart rate</measure>
    <time_frame>Weeks 2, 4, 8, 12, 16, 24, 32 and 48.</time_frame>
    <description>Heart rate in beats per minutes</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">849</enrollment>
  <condition>Osteoarthritis, Hip</condition>
  <condition>Osteoarthritis, Knee</condition>
  <arm_group>
    <arm_group_label>Low dose</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Investigational product</description>
  </arm_group>
  <arm_group>
    <arm_group_label>High dose</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Investigational product</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Investigational product</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Tanezumab</intervention_name>
    <description>2.5 mg</description>
    <arm_group_label>Low dose</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Tanezumab</intervention_name>
    <description>5 mg</description>
    <arm_group_label>High dose</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  A diagnosis of osteoarthritis of the index hip or knee based on American College of
             Rheumatology criteria with Kellgren Lawrence x-ray Grade of at least 2 as diagnosed by
             the Central Reader

          -  A history of insufficient pain relief from acetaminophen along with a history of
             insufficient pain relief from, inability to tolerate or contraindication to taking
             NSAIDs, and tramadol or opioid treatments.

          -  WOMAC Pain subscale score of at least 5 in the index hip or knee at Screening.

          -  Be willing to discontinue all non study pain medications for osteoarthritis and not
             use prohibited pain medications throughout the duration of the study.

          -  Female subjects of childbearing potential must agree to comply with protocol specified
             contraceptive requirements.

        Exclusion Criteria:

          -  Subjects exceeding protocol defined BMI or body weight limits.

          -  History of other diseases specified in the protocol (e.g. inflammatory joint diseases,
             crystalline diseases such as gout or pseudogout) that may involve the index joint and
             that could interfere with efficacy assessments.

          -  Radiographic evidence of protocol specified bone or joint conditions in any screening
             radiograph as determined by the central radiology reviewer.

          -  A history of osteonecrosis or osteoporotic fracture.

          -  History of significant trauma or surgery to a knee, hip or shoulder within the
             previous year.

          -  Planned surgical procedure during the duration of the study.

          -  Presence of conditions (e.g. fibromyalgia, radiculopathy) associated with moderate to
             severe pain that may confound assessments or self evaluation of osteoarthritis pain.

          -  Signs or symptoms of carpal tunnel syndrome in the year prior to Screening.

          -  Considered unfit for surgery based upon American Society of Anesthesiologists physical
             classification system for surgery grading, or subjects who would not be willing to
             undergo joint replacement surgery if required.

          -  History of intolerance or hypersensitivity to acetaminophen or any of its excipients
             or existence of a medical condition or use of concomitant medication for which the use
             of acetaminophen is contraindicated.

          -  Use of prohibited medications without the appropriate washout period prior to
             Screening or Initial Pain Assessment Period.

          -  History of cancer within 5 years of Screening, except for cutaneous basal cell or
             squamous cell cancer resolved by excision.

          -  Subjects with signs and symptoms of clinically significant cardiac disease as
             described in the protocol.

          -  Diagnosis of a transient ischemic attack in the 6 months prior to Screening, diagnosis
             of stroke with residual deficits that would preclude completion of required study
             activities.

          -  History, diagnosis, or signs and symptoms of clinically significant neurological
             disease such as but not limited to peripheral or autonomic neuropathy.

          -  History, diagnosis, signs or symptoms of any clinically significant psychiatric
             disorder.

          -  History of known alcohol, analgesic or drug abuse within 2 years of Screening.

          -  Previous exposure to exogenous NGF or to an anti-NGF antibody.

          -  History of allergic or anaphylactic reaction to a therapeutic or diagnostic monoclonal
             antibody or IgG fusion protein.

          -  Poorly controlled hypertension as defined in the protocol or taking an
             antihypertensive that has not been stable for at least 1 month prior to Screening.

          -  Evidence of protocol defined orthostatic hypotension at Screening.

          -  Disqualifying score on the Survey of Autonomic Symptoms questionnaire at Screening.

          -  Screening AST, ALT, serum creatinine or HbA1c values that exceed protocol defined
             limits.

          -  Presence of drugs of abuse in screening urine toxicology panel.

          -  Positive hepatitis B, hepatitis C or HIV test results indicative of current infection.

          -  Participation in other investigational drug studies within protocol defined time
             limits.

          -  Pregnant, breastfeeding or female subjects of childbearing potential who are unwilling
             or unable to follow protocol required contraceptive requirements.

          -  Other severe acute or chronic medical or psychiatric condition or laboratory
             abnormality that in the judgment of the investigator, would make the subject
             inappropriate for entry into this study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pfizer CT.gov Call Center</last_name>
    <role>Study Director</role>
    <affiliation>Pfizer</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Nuhr Medical Center</name>
      <address>
        <city>Senftenberg</city>
        <zip>3541</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rheuma Zentrum Favoriten</name>
      <address>
        <city>Wien</city>
        <zip>1100</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Center BLAGOEVGRAD 2009, EOOD</name>
      <address>
        <city>Blagoevgrad</city>
        <zip>2700</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>DCC St. Pantaleimon OOD</name>
      <address>
        <city>Pleven</city>
        <zip>5800</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Center &quot; Health for all&quot; EOOD</name>
      <address>
        <city>Plovdiv</city>
        <zip>4000</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UMHAT &quot;Kaspela&quot; EOOD, Clinic of Rheumatology</name>
      <address>
        <city>Plovdiv</city>
        <zip>4001</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>&quot;Medical Center Teodora&quot; EOOD</name>
      <address>
        <city>Ruse</city>
        <zip>7012</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Multiprofile Hospital for Active Treatment-Silistra AD</name>
      <address>
        <city>Silistra</city>
        <zip>7500</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>&quot;Medical Center- Smolyan&quot; OOD</name>
      <address>
        <city>Smolyan</city>
        <zip>4700</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>NMTH 'Tsar Boris III&quot;. Clinic of Internal Diseases</name>
      <address>
        <city>Sofia</city>
        <zip>1233</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Multiprofile hospital for active treatment - &quot;Lyulin&quot; EAD</name>
      <address>
        <city>Sofia</city>
        <zip>1336</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Diagnostic Consultative Center XIV- Sofia EOOD</name>
      <address>
        <city>Sofia</city>
        <zip>1408</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Centre-Avicena EOOD</name>
      <address>
        <city>Sofia</city>
        <zip>1408</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UMHAT Sveti Ivan Rilski - EAD</name>
      <address>
        <city>Sofia</city>
        <zip>1612</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UMHAT &quot;Sofiamed&quot; OOD, Block 2</name>
      <address>
        <city>Sofia</city>
        <zip>1750</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>&quot;Medical Center - Dr. Hayvazov&quot; EOOD</name>
      <address>
        <city>Sofia</city>
        <zip>1784</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UMHAT &quot;Prof. Dr. Stoyan Kirkovich&quot; AD</name>
      <address>
        <city>Stara Zagora</city>
        <zip>6000</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Multiprofile Hospital for active treatment &quot;SVETA PETKA&quot; AD</name>
      <address>
        <city>Vidin</city>
        <zip>3700</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dextra Oy/Pihlajalinna Ite Kuopio</name>
      <address>
        <city>Kuopio</city>
        <zip>70100</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Oulu Deaconess Institute</name>
      <address>
        <city>Oulu</city>
        <zip>90100</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Edouard Herriot</name>
      <address>
        <city>Lyon</city>
        <zip>69003</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Unite Clinique Therapeutique des Maladies Osteoarticulaires</name>
      <address>
        <city>Montpellier Cedex 5</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHR Orleans La Source</name>
      <address>
        <city>Orleans</city>
        <zip>45067</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hopital Lariboisiere</name>
      <address>
        <city>Paris cedex 10</city>
        <zip>75475</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hopital Saint-Antoine</name>
      <address>
        <city>Paris cedex 12</city>
        <zip>75571</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Cochin</name>
      <address>
        <city>Paris cedex 14</city>
        <zip>75659</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hopital Cochin</name>
      <address>
        <city>Paris cedex 14</city>
        <zip>75679</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rheumapraxis</name>
      <address>
        <city>Aachen</city>
        <zip>52064</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rheumazentrum Prof. Dr. med Gunther Neeck</name>
      <address>
        <city>Bad Doberan</city>
        <zip>18209</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kerckhoff Klinik GmbH</name>
      <address>
        <city>Bad Nauheim</city>
        <zip>61231</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Charite Universitaetsmedizin Berlin</name>
      <address>
        <city>Berlin</city>
        <zip>10117</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CIRI GmbH</name>
      <address>
        <city>Frankfurt am Main</city>
        <zip>60590</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Praxis Dr. Schmidt</name>
      <address>
        <city>Offenbach</city>
        <zip>63073</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bekes Megyei Központi Korhaz Dr Rethy Pal Tagkorhaz, Reumatologia Szakrendeles</name>
      <address>
        <city>Bekescsaba</city>
        <zip>5600</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinexpert Egeszsegugyi Szolgaltato es Kereskedelmi Kft.</name>
      <address>
        <city>Budapest</city>
        <zip>1033</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Obudai Egeszsegugyi Centrum Kft</name>
      <address>
        <city>Budapest</city>
        <zip>1036</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Qualiclinic Kft.</name>
      <address>
        <city>Budapest</city>
        <zip>1036</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Jutrix Kft</name>
      <address>
        <city>Kecskemét</city>
        <zip>6000</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tolna Megyei Balassa Janos Korhaz, Ortopediai osztaly</name>
      <address>
        <city>Szekszard</city>
        <zip>7100</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Istituto Clinico Humanitas Unita Operativa di Medicina Generale e Reumatologia -</name>
      <address>
        <city>Rozzano</city>
        <state>Milan</state>
        <zip>20089</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera-Universitaria S.Orsola-Malpighi</name>
      <address>
        <city>Bologna</city>
        <zip>40138</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Farmacia Clinica Puggioli</name>
      <address>
        <city>Bologna</city>
        <zip>40138</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>AZ OSPEDALIERO - UNIVERSITARIA CAREGGI-SOD Reumatologia - Dip. Medicina Sperimentale e Clinica</name>
      <address>
        <city>Firenze</city>
        <zip>50134</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Farmacia AOUC Settore Sperimentazione Farmaci</name>
      <address>
        <city>Firenze</city>
        <zip>50134</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>AOU Maggiore della Carita di Novara - S.C. Medicina Fisica e Riabilitativa</name>
      <address>
        <city>Novara</city>
        <zip>28100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dipartimento Immagini Radiologia</name>
      <address>
        <city>Novara</city>
        <zip>28100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Farmacia Ospedaliera</name>
      <address>
        <city>Novara</city>
        <zip>28100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliero-Universitaria E Policlinico Umberto I</name>
      <address>
        <city>Rome</city>
        <zip>00161</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera Universitaria Senese - UOC Reumatologia,</name>
      <address>
        <city>Siena</city>
        <zip>53100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>U.O.C. Farmacia - Gestione medicinali per la sperimentazione clinica</name>
      <address>
        <city>Siena</city>
        <zip>53100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale Civile Maggiore Borgo Trento</name>
      <address>
        <city>Verona</city>
        <zip>37126</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sato Orthopedic Clinic</name>
      <address>
        <city>Ichikawa</city>
        <state>Chiba</state>
        <zip>272-0021</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kamagaya General Hospital</name>
      <address>
        <city>Kamagaya</city>
        <state>Chiba</state>
        <zip>273-0121</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fukuoka Mirai Hospital</name>
      <address>
        <city>Higashi-ku,Fukuoka</city>
        <state>Fukuoka</state>
        <zip>813-0017</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Shinkokura Hospital</name>
      <address>
        <city>Kitakyushu</city>
        <state>Fukuoka</state>
        <zip>803-8505</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Obase Hospital</name>
      <address>
        <city>Miyako-gun</city>
        <state>Fukuoka</state>
        <zip>800-0344</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Takagi Hospital</name>
      <address>
        <city>Okawa</city>
        <state>Fukuoka</state>
        <zip>831-0016</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Himeno Hospital</name>
      <address>
        <city>Yamegun</city>
        <state>Fukuoka</state>
        <zip>834-0115</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Takahashi Orthopedics Clinic</name>
      <address>
        <city>Chitose</city>
        <state>Hokkaido</state>
        <zip>066-0062</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hakodate Central General Hospital</name>
      <address>
        <city>Hakodate</city>
        <state>Hokkaido</state>
        <zip>040-8585</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hakodate Ohmura Orthopedic Hospital</name>
      <address>
        <city>Hakodate</city>
        <state>Hokkaido</state>
        <zip>041-0802</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Obihiro Orthopaedic Hospital</name>
      <address>
        <city>Obihiro</city>
        <state>Hokkaido</state>
        <zip>080-0802</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Okubo Hospital</name>
      <address>
        <city>Akashi</city>
        <state>Hyogo</state>
        <zip>674-0051</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kobe Kaisei Hospital</name>
      <address>
        <city>Kobe</city>
        <state>Hyogo</state>
        <zip>657-0068</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kobe Konan Yamate clinic</name>
      <address>
        <city>Kobe</city>
        <state>Hyogo</state>
        <zip>658-0011</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>National Hospital Organization Sagamihara National Hospital</name>
      <address>
        <city>Sagamihara</city>
        <state>Kanagawa</state>
        <zip>252-0392</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Corporation Association Sankikai, Yokohama Shinmidori General Hospital</name>
      <address>
        <city>Yokohama</city>
        <state>Kanagawa</state>
        <zip>226-0025</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Marunouchi Hospital</name>
      <address>
        <city>Matsumoto</city>
        <state>Nagano</state>
        <zip>390-8601</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>National Hospital Organization Nagasaki Medical Center</name>
      <address>
        <city>Omura</city>
        <state>Nagasaki</state>
        <zip>856-8562</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sobajima Clinic/Orthopedics</name>
      <address>
        <city>Higashiosaka</city>
        <state>Osaka</state>
        <zip>577-0011</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>National Hospital Organization Osaka Minami Medical Center</name>
      <address>
        <city>Kawachinagano</city>
        <state>Osaka</state>
        <zip>586-8521</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hamamatsu Medical Center</name>
      <address>
        <city>Hamamatsu</city>
        <state>Shizuoka</state>
        <zip>432-8580</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>National Hospital Organization Utsunomiya national Hospital</name>
      <address>
        <city>Utsunomiya</city>
        <state>Tochigi</state>
        <zip>329-1193</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sonodakai Joint Replacement Center Hospital</name>
      <address>
        <city>Adachi-ku</city>
        <state>Tokyo</state>
        <zip>121-0064</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kitasato University Kitasato Institute Hospital</name>
      <address>
        <city>Minato-ku</city>
        <state>Tokyo</state>
        <zip>108-8642</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ohimachi Orthopaedic Clinic</name>
      <address>
        <city>Shinagawa-ku</city>
        <state>Tokyo</state>
        <zip>140-0014</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Akita City Hospital</name>
      <address>
        <city>Akita</city>
        <zip>010-0933</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kyushu Central Hospital</name>
      <address>
        <city>Fukuoka</city>
        <zip>815-8588</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hiroshima Clinic</name>
      <address>
        <city>Hiroshima</city>
        <zip>733-0032</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Jujo Takeda Rehabilitation Hospital</name>
      <address>
        <city>Kyoto</city>
        <zip>601-8325</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nagayoshi General Hospital</name>
      <address>
        <city>Osaka</city>
        <zip>547-0016</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>NZOZ OSTEO-MEDIC s.c. A. Racewicz, J. Supronik</name>
      <address>
        <city>Bialystok</city>
        <zip>15-351</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ClinicMed Daniluk, Nowak Społka Jawna</name>
      <address>
        <city>Bialystok</city>
        <zip>15-879</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centrum Kliniczno - Badawcze J. Brzezicki, B. Gornikiewicz - Brzezicka Lekarze Spolka Partnerska</name>
      <address>
        <city>Elblag</city>
        <zip>82-300</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centrum Medyczne Pratia Gdynia</name>
      <address>
        <city>Gdynia</city>
        <zip>81-338</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centrum Medyczne Pratia Krakow</name>
      <address>
        <city>Krakow</city>
        <zip>30-002</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Malopolskie Centrum Medyczne S.C</name>
      <address>
        <city>Krakow</city>
        <zip>30-510</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centrum Terapii Wspolczesnej J.M Jasnorzewska</name>
      <address>
        <city>Lodz</city>
        <zip>90-242</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>MTZ Clincial Research Sp. z o.o.</name>
      <address>
        <city>Warszawa</city>
        <zip>02-106</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>REUMATIKA - Centrum Reumatologii NZOZ</name>
      <address>
        <city>Warszawa</city>
        <zip>02-691</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Conde de Bertiandos</name>
      <address>
        <city>Ponte De Lima</city>
        <state>Viana DO Castelo</state>
        <zip>4990-041</zip>
        <country>Portugal</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centro Hospitalar Lisboa Ocidental, E.P.E., Hospital Egas Moniz</name>
      <address>
        <city>Lisboa</city>
        <zip>1349-019</zip>
        <country>Portugal</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Egas Moniz</name>
      <address>
        <city>Lisboa</city>
        <zip>1349-019</zip>
        <country>Portugal</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>SC Duo Medical SRL</name>
      <address>
        <city>Bucuresti</city>
        <state>Sector 1</state>
        <zip>010584</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centrul Medical SANA S.R.L.</name>
      <address>
        <city>Bucuresti</city>
        <state>Sector 1</state>
        <zip>011025</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Spitalul Judetean de Urgenta Bacau</name>
      <address>
        <city>Bacau</city>
        <zip>600114</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Spitalul Clinic &quot;Sf. Maria&quot;</name>
      <address>
        <city>Bucuresti</city>
        <zip>011172</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Spitalul Clinic Judetean de Urgenta Sf. Apostoi Andrei Constanta</name>
      <address>
        <city>Constanta</city>
        <zip>900591</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Spitalul Clinic Judetean de Urgenta Sibiu</name>
      <address>
        <city>Sibiu</city>
        <zip>550245</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>AB-BA ambulancia s.r.o.</name>
      <address>
        <city>Bratislava</city>
        <zip>851 07</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ROMJAN s.r.o.</name>
      <address>
        <city>Bratislava</city>
        <zip>85101</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kompan, s.r.o</name>
      <address>
        <city>Dolny Kubín</city>
        <zip>02601</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ALGMED s.r.o.</name>
      <address>
        <city>Kosice</city>
        <zip>040 01</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Reum. hapi s.r.o.</name>
      <address>
        <city>Nove Mesto nad Vahom</city>
        <zip>915 01</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medipa s.r.o.</name>
      <address>
        <city>Piestany</city>
        <zip>921 01</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>MUDr. Viliam Cibik, PhD, s.r.o.</name>
      <address>
        <city>Pruske</city>
        <zip>018 52</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Reumex s.r.o</name>
      <address>
        <city>Rimavska Sobota</city>
        <zip>979 01</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital La Esperanza</name>
      <address>
        <city>Santiago de Compostela</city>
        <state>A Coruna</state>
        <zip>15705</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Corporacio Sanitaria Parc Tauli de Sabadell</name>
      <address>
        <city>Sabadell</city>
        <state>Barcelona</state>
        <zip>08208</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Corporació Sanitaria Parc Taulí de Sabadell</name>
      <address>
        <city>Sabadell</city>
        <state>Barcelona</state>
        <zip>08208</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Marques de Valdecilla.</name>
      <address>
        <city>Santander</city>
        <state>Cantabria</state>
        <zip>39008</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Marqués de Valdecilla</name>
      <address>
        <city>Santander</city>
        <state>Cantabria</state>
        <zip>39008</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario de Getafe</name>
      <address>
        <city>Getafe</city>
        <state>Madrid</state>
        <zip>28905</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Complejo Hospital Universitario A Coruna (CHUAC)</name>
      <address>
        <city>A Coruna</city>
        <zip>15006</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital La Esperanza</name>
      <address>
        <city>A Coruña</city>
        <zip>15705</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Instituto de Ciencias Medicas</name>
      <address>
        <city>Alicante</city>
        <zip>03004</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Instituto de Ciencias Médicas</name>
      <address>
        <city>Alicante</city>
        <zip>03004</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital del Mar (Drug shipment delivery only)</name>
      <address>
        <city>Barcelona</city>
        <zip>08003</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital del Mar</name>
      <address>
        <city>Barcelona</city>
        <zip>08003</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital CIMA Sanitas</name>
      <address>
        <city>Barcelona</city>
        <zip>08034</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Reina Sofia.</name>
      <address>
        <city>Cordoba</city>
        <zip>14004</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Reina Sofia</name>
      <address>
        <city>Cordoba</city>
        <zip>14004</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario de Getafe</name>
      <address>
        <city>Getafe, Madrid</city>
        <zip>28905</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital General Universitario de Guadalajara</name>
      <address>
        <city>Guadalajara</city>
        <zip>19002</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario La Princesa Farmacia - Ensayos Clinicos</name>
      <address>
        <city>Madrid</city>
        <zip>28006</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario La Princesa</name>
      <address>
        <city>Madrid</city>
        <zip>28006</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario La Paz Servicio de Farmacia</name>
      <address>
        <city>Madrid</city>
        <zip>28046</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario La Paz</name>
      <address>
        <city>Madrid</city>
        <zip>28046</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Regional Universitario de Malaga. Farmacia del Hospital Civil</name>
      <address>
        <city>Malaga</city>
        <zip>29009</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Regional Universitario de Malaga</name>
      <address>
        <city>Malaga</city>
        <zip>29009</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Infanta Luisa</name>
      <address>
        <city>Sevilla</city>
        <zip>41010</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ladulaas Kliniska Studier</name>
      <address>
        <city>Boras</city>
        <zip>SE-50630</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CTC (Clinical Trial Center), Sahlgrenska University Hospital</name>
      <address>
        <city>Gothenburg</city>
        <zip>413 45</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ProbarE i Lund AB</name>
      <address>
        <city>Lund</city>
        <zip>222 22</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>PharmaSite</name>
      <address>
        <city>Malmo</city>
        <zip>211 52</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Avdelningen for kliniska provningar, S-huset</name>
      <address>
        <city>Orebro</city>
        <zip>703 62</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Karolinska Trial Alliance, Fas 1</name>
      <address>
        <city>Stockholm</city>
        <zip>141 86</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Karolinska Trial Alliance, KTA.</name>
      <address>
        <city>Stockholm</city>
        <zip>141 86</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ProbarE i Stockholm AB</name>
      <address>
        <city>Stockholm</city>
        <zip>171 45</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Alverton Practice</name>
      <address>
        <city>Penzance</city>
        <state>Cornwall</state>
        <zip>TR18 4JH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Brannel Surgery</name>
      <address>
        <city>St. Austell</city>
        <state>Cornwall</state>
        <zip>PL26 7RL</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Knowle House Surgery</name>
      <address>
        <city>Plymouth</city>
        <state>Devon</state>
        <zip>PL5 3JB</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Western General Hospital</name>
      <address>
        <city>Edinburgh</city>
        <state>Lothian</state>
        <zip>EH4 2XU</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinical Trials, Bradford on Avon Health Centre</name>
      <address>
        <city>Bradford on Avon</city>
        <zip>BA15 1DQ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Health Centre, Bradford on Avon &amp; Melksham Health Partnership</name>
      <address>
        <city>Bradford on Avon</city>
        <zip>BA15 1DQ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Oxford University Hospitals NHS Foundation Trust</name>
      <address>
        <city>Headington, Oxford</city>
        <zip>OX3 7LD</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Oxford University Hospitals NHS Foundation Trust</name>
      <address>
        <city>Headington, Oxford</city>
        <zip>OX3 7LE</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St George's University Hospitals NHS Foundation Trust</name>
      <address>
        <city>London</city>
        <zip>SW17 0QT</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Northumbria Healthcare NHS Foundation Trust</name>
      <address>
        <city>North Shields</city>
        <zip>NE29 8NH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nuffield Department of Orthopaedics</name>
      <address>
        <city>Oxford</city>
        <zip>OX3 7HE</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
    <country>Bulgaria</country>
    <country>Finland</country>
    <country>France</country>
    <country>Germany</country>
    <country>Hungary</country>
    <country>Italy</country>
    <country>Japan</country>
    <country>Poland</country>
    <country>Portugal</country>
    <country>Romania</country>
    <country>Slovakia</country>
    <country>Spain</country>
    <country>Sweden</country>
    <country>United Kingdom</country>
  </location_countries>
  <link>
    <url>https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=A4091057</url>
    <description>To obtain contact information for a study center near you, click here.</description>
  </link>
  <link>
    <url>https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=A4091057&amp;StudyName=A+Phase+3+Randomized%2C+Double-blind%2C+Placebo-controlled%2C+Multicenter+Study+Of+The+Analgesic+Efficacy+And+Safety+Of+The+Subcutaneous+Administration+Of+Tanezumab+In+Subjects+With+Osteoarthritis+Of+The+Hip+Or+Knee</url>
    <description>To obtain contact information for a study center near you, click here.</description>
  </link>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 26, 2016</study_first_submitted>
  <study_first_submitted_qc>March 10, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 16, 2016</study_first_posted>
  <last_update_submitted>May 16, 2018</last_update_submitted>
  <last_update_submitted_qc>May 16, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 17, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Osteoarthritis, pain, tanezumab.</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Osteoarthritis, Knee</mesh_term>
    <mesh_term>Osteoarthritis, Hip</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Analgesics</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

